Skip to content


Featured article: Reactivation of dormant anti-tumor immunity – a clinical perspective of therapeutic immune checkpoint modulation

© Copywrite Richard Greil

Tumor immunotherapy has a long-standing history.  This review covers some aspects of the immunological basis necessary to understand the rapidly developing therapeutic field in cancer treatment, and the clinical achievements that have been made.  It also addresses some current questions in translational research in this field.


Most accessed articles RSS

View all articles

Aims and scope

Cell Communication and Signaling is an open access journal that encompasses all basic and translational aspects of cellular communications and signaling pathways in normal and pathological conditions.

Read more

CCS Upcoming Meetings

New Content Item

The International Cell Death and Society meeting will take place May 30-June 2, 2018 at Seoul National University, in Seoul, South Korea.  

The theme of this year's meeting is "About canonical, non-canonical, and immunogenic cell death: basic mechanisms and translational applications".

The 'International Lecture Series on Disease Biology and Molecular Medicine' has a series of ongoing meetings organized by the Medical Faculty of the Martin-Luther-University Halle-Wittenberg with support from the City of Halle. The International Lecture Series on Disease Biology and Molecular Medicine showcases a wide range of biomedical research areas and fosters collaboration in the scientific community.

Read more

Other sponsorships

Please check out some of the sponsorships Cell Communication and Signaling has participated in over the last few years, including lectures, symposiums, round tables, and travel fellowships.

Editor's profile

New Content Item (1)Raymond Birge, Editor-in-Chief

Raymond Birge, PhD., is a Professor at Rutgers, The State University of New Jersey and member of the New Jersey Medical School Cancer Center. Dr. Birge joined UMDNJ-New Jersey Medical School in 2000 and currently holds a position of Professor and Vice Chair for Research in the Department of Microbiology, Biochemistry and Molecular Biology. Dr. Birge also has joint appointments at the New Jersey Medical School Cancer Center (Newark) and the Cancer Institute of New Jersey (New Brunswick).  

Read more


2017 Journal Metrics